BC Advantage - 2025 Issue 1

CMS Issues Permanent Reimbursement Code for Anktiva

The Centers for Medicare & Medicaid Services (CMS) issued the Healthcare Common Procedure Coding System (HCPCS) J-code J9028 for billing and reimbursement of nogapendekin alfa inbakicept-pmln (Anktiva; N-803), as announced by ImmunityBio in a recent press release.   Approval and Application of Anktiva   Anktiva received FDA approval in April 2024 for use in combination with BCG to treat patients with BCG-unresponsive non–muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors. The newly issued J-code for Anktiva became effective on January 1, 2025. This code is expected to simplify the billing and...

To read the full article, sign in and subscribe to BC Advantage.

Thank you for choosing Find-A-Code, please Sign In to remove ads.